RHEUMATOLOGY

The Division of Rheumatology promotes prevention, cure and relief of suffering caused by arthritis and rheumatic diseases through research, education and patient care. Our diverse faculty are world-renowned experts in all spectrums of rheumatic disease including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, osteoarthritis, scleroderma, systemic lupus erythematosus, gout, myositis and vasculitis. Our scleroderma and vasculitis clinical programs are among the largest in the nation.

​We are one of the few rheumatology programs in the country that has a dedicated ultrasound-imaging clinic, which maintains the state-of-the-art equipment as well as being the center for experimental procedures such as ultrasound-guided synovial biopsies. The central focus of our research is predicated on being transformative, translational and collaborative. Our projects center on providing better treatments for our patients, identifying new therapeutics or the underlying basis of disease, and establishing a precision medicine approach. ​

Clinical trials in RHEUMATOLOGY

Synovial Macrophage Transcriptional Signatures for Predicting Therapeutic Efficacy

Principal Investigator: Harris R. Perlman, PhD

XIRB A Master Protocol for Randomized, Placebo-Controlled, Phase 2 Clinical Trials of Multiple Interventions for the Treatment of Chronic Pain

​Principal Investigator: Thomas J. Schnitzer, MD, PhD
To view all clinical trials, visit Clinical Trials at Northwestern University Feinberg School of Medicine.

Find an Expert

Northwestern Medicine welcomes the opportunity to collaborate with you on the care of your patients.

Find an NM Rheumatologist

Meet the Rheumatology Faculty at Northwestern University Feinberg School of Medicine

We are committed to improving human health through education and discovery.

MEET OUR FACULTY

Updates from Northwestern medicine RHEUMATOLOGY

​Many patients with rheumatoid arthritis (RA) fail to notify their rheumatologists of flares occurring between appointments and instead try to manage flares on their own. Mobile apps present a unique opportunity to improve real-time assessment and management of RA by collecting electronic patient-reported outcomes (ePROs) between appointments. Such data can help identify sustained increases in these ePROs that may benefit from early intervention. Yvonne C. Lee, MD, MMSc, examined the effects of using an app to monitor longitudinal ePROs on patient satisfaction and disease activity in patients with RA. 

Follow Northwestern Medicine Rheumatology